flow; essential hypertension; glomerular filtration rate; renal functional reserve
controls.

Methods. Renal clearances of sinistrin, an inulin-like
Sensitive clinical methods for detecting early changes polyfructosan, and p-aminohippurate were determined in renal vascular reactivity of patients with essential before and after protein ingestion. These tests were hypertension have been lacking to date [1] . Because performed in healthy controls and in patients with of possible hyperfiltration [2] , single clearance measessential hypertension (mean arterial pressure of urements cannot detect vascular changes, which may 112±2 mmHg, age, 52±2 years; mean±SEM ) within be induced by hypertension or reversed by antihypera washout period, and after long-term treatment with tensive treatment. Therefore, dynamic renal function carvedilol and fosinopril, respectively.
tests, which consist of two consecutive kinetic clearance Results. In 15 healthy volunteers, protein ingestion measurements before and after a dietary protein load, increased glomerular filtration rate (GFR) from have been tried previously in patients at risk for 110.3±3.6 to 120.6±4.4 ml/min (P=0.0006; twohypertensive renal damage in order to assess the extent tailed pairwise t-test). In contrast, it led to an acute of renal vascular impairment [3] . In healthy subjects, decrease in GFR in 16 hypertensive patients, from increases in glomerular filtration rate (GFR) after 111.8±2.9 to 103.6±3.3 ml/min (P=0.0010). The protein ingestion have been uniformly observed [4] , eight patients who were randomized to receive carvedibut in patients with essential hypertension most lol improved in their renal response to protein (GFR authors have found 'blunted increases' in GFR after increased from 101.4±6.4 to 107.1±5.4 ml/min; P= dietary stresses [5] . This so-called 'blunted increase' in 0.04), whereas the eight other patients randomized to GFR was originally thought to be due to an increase receive fosinopril exhibited no change in GFR (final in intraglomerular pressure. However, the alleged value 105±4.9 ml/min). In the patients, the acute shifts increase in GFR in response to protein ingestion was in renal plasma flows were not significant. Mean arternot accompanied by a change in albumin excretion, ial blood pressure of the patients decreased from and there was lack of dynamic GFR response after 112±2 to 100±3 mmHg (P=0.0015).
administration of ACE inhibitors.
Conclusions. In essential hypertension an acute protein
These contradictory results suggest that the earlier load induces a decrease in GFR that may normalize dynamic test methods that described qualitatively under antihypertensive treatment. The acute changes normal increases in GFR after amino acid stimulation in GFR can be reliably monitored by the herewere probably not sensitive enough. Stationary creatindescribed compartmental analysis method of renal ine levels cannot reveal short-term changes in clearfunctional reserve.
ance. Traditional steady-state methods of GFR determination [6 ] are inappropriate for acute evaluKeywords: dietary protein load; effective renal plasma ation of dynamic changes in kidney function because of their mathematical naiveté. The 'gold standard' in renal clearance determinations formerly consisted of relating the urinary elimination rate to the correspondCorrespondence and offprint requests to: Dr Sabine Zitta, Department ing plasma concentration level of an excreted marker clearance determinations. Evaluation was done by Subjects and methods forming the ratio of infusion or elimination rate and the steady-state marker level. These methods required The subjects included 15 healthy controls (four male, 11 equilibration of marker concentrations between the female, mean age 44.1±2. 3 for calculation of renal clearance are correct only over chosen for 6 months treatment with the b-adrenoceptora long experimental time horizon [8] . However, in blocker carvedilol. The other eight patients were chosen for dynamic renal function testing the experimental time 6 months treatment with the ACE inhibitor fosinopril. All horizons are necessarily limited for practical reasons. subjects were studied first after a 2-week washout period A mathematical extension for the description of without antihypertensive drugs, and again after 6 months of time-dependent non-steady-state processes is given by treatment with either carvedilol or fosinopril. All subjects had a normal serum creatinine level, normal creatinine the superposition of exponential functions. These clearance, no proteinuria, and no history of any renal disease.
empirical models implicitly represent processes of
The determination of renal functional reserve requires the marker distribution and elimination in one or more stimulation of renal function by amino acid infusion or a compartments [9] . However, only the concentration protein-rich meal [14] . We chose an artificially protein-rich profile in the so-called central compartment, i.e. the meal for protein supplementation in order to avoid the local blood compartment, is studied after a single injection pain and phlebitis noted in preliminary experiments using of a marker bolus. Furthermore, only situations with peripheral intravenous administration of amino acids. The initial marker concentrations of zero before marker time-span chosen for protein ingestion was motivated by previous studies [15] in healthy humans that showed that application are considered. GFR changes from one constant level to another approxiIn a model for dynamic renal function testing, mately 90 min after ingestion of amino acids. In these studies however, marker amounts that remain in the extracelthe new GFR remained constant for at least 3 h. lular space from the first kinetic experiment have to Subjects were instructed to eat a low-protein diet for 2 be taken into account for evaluation in an immediately days before the examination. On the morning of the test following experiment. In order to take into account they had been fasting since midnight. Every hour the test non-zero initial marker concentrations, a more flexible subjects were given 4 ml of water/kg body weight, and approach was employed that avoided the stereotypical remained recumbent throughout the entire study We investigated the suitability of system identifica-dosage of fosinopril was 10-20 mg/day. Dosages of the drugs tion as applied to a two-compartment model for quant-were then adjusted to achieve a desired MAP goal of itative assessment of protein-rich meals on renal 100 mmHg. The study was approved by the local ethics function. In order to evaluate the dynamic renal func-committee, and the subjects had given informed consent. tion testing procedure we studied the dynamic test
The evaluations of the dynamic renal function tests were performed by adapting the basic model of pharmacokinetics response defined as the immediate change in clearance to the marker concentration profiles. The methods involved following the dietary protein load in healthy controls have been described previously [16, 17] . All clearance estimand in some hypertensive patients. In addition, two ates referred to 1.73 m2 body surface area. Paired and groups of hypertensive patients, which were formed unpaired Student's two-tailed t-tests were used for comparrandomly from the larger group, were tested prior to ison of group mean values. All means are given with their and following long-term treatment with the b-adreno-SEM. The statistical evaluations were done by means of the receptor blocker carvedilol and the angiotensin spreadsheet program Microsoft Excel ( Version 5.0). converting enzyme (ACE)-inhibitor fosinopril, respectively. The aim of our study was to test whether or not Results the dynamic test method can detect alterations in renal vascular status in patients with essential hypertension by determination of acute renal functional change The temporal concentration profile of sinistrin in a hypertensive patient during the initial dynamic study following protein ingestion [13] .
is shown in Figure 1 . It illustrates the studies and term pathophysiological and treatment-dependent changes in renal functional responses to dietary stimuli. evaluations done on all tested subjects. Figure 2 shows the MAP in the normotensive con-The essence of this is shown in Figure 3 and it can be seen that in normotensive controls the mean GFR trols, the hypertensive patients during the washout period, and the same hypertensive patients after long-increases upon protein stimulation whereas in hypertensive patients it decreases. There is a tendency term antihypertensive treatment. There is a long-term decrease in blood pressure, but no acute change in towards normalization of the dynamic test response to protein stimulation in the hypertensive patients after MAP due to the dietary stimulus during the dynamic renal function studies.
long-term antihypertensive treatment due to the effect of carvedilol. Figures 3 to 7 illustrate that the method of dynamic renal function testing allows the monitoring of longIn Figure 4 the mean ERPF for normotensive con- Differences between baseline and test MAPs are not significant. Fig. 3 . GFR during baseline and test clearance experiments, i.e. before and after protein ingestion, respectively. NT, normotensive controls (n=15); HT0, hypertensive patients during washout phase (n=16); HTt, same hypertensive patients after long-term antihypertensive treatment (n=16). Error bars denote SEM. Differences in corresponding GFRs between groups NT, HT0 , and HTt are not significant, except for the difference in baseline GFRs between HT0 and HTt (P=0.02). Differences between baseline and test GFRs are significant (P<0.001) in both NT and HT0. Fig. 4 . ERPF during baseline and test clearance experiments, i.e. before and after protein ingestion, respectively. NT, normotensive controls (n=12); HT0, hypertensive patients during washout phase (n=12); HTt, same hypertensive patients after long-term antihypertensive treatment (n=12). Error bars denote SEM. The difference in baseline ERPFs between groups NT and HT0 is significant (P<0.05). The difference between baseline and test GFRs is significant (P=0.0021) in NT only. trols increases upon protein stimulation, but in hyperAs Figures 5 and 6 indicate, both subgroups of hypertensive patients initially show about the same tensive patients it remains the same. There is a tendency towards normalization of the dynamic test response to decrease in GFR upon protein stimulation. Regarding the renal functional response after long-term treatment, protein stimulation in the hypertensive patients after long-term antihypertensive treatment. A striking fea-however, there seems to be a fundamental difference in the actions of carvedilol and fosinopril. Figure 5 ture of these results is the large difference in ERPF between normotensive subjects and hypertensive shows that after long-term treatment with carvedilol there is an increase in GFR upon protein stimulation. patients. This difference does not disappear with longterm antihypertensive treatment. Both antihypertensive A restoration of the response exhibited by the normal controls is achieved by the treatment. Figure 6 shows drugs, carvedilol and fosinopril, led to the same decrease in MAP as illustrated in Figure 2 for the total that after long-term treatment with fosinopril, GFR before and after protein stimulation remains the same. group of hypertensive patients after long-term treatment.
Thus it seems that if there was any response at all, it Fig. 5 . GFR in the hypertensive group randomly chosen for treatment with carvedilol during baseline and test clearance experiments, i.e. before and after protein ingestion, respectively. NT, normotensive controls (n=15); HT0(C ), hypertensive patients chosen for treatment with carvedilol during washout phase (n=8); HTt(C ), same hypertensive patients after long-term antihypertensive treatment with carvedilol (n=8). Error bars denote SEM. Differences in corresponding GFRs between groups HT0(C ) and HTt(C ) are not significant. Differences between baseline and test GFRs are significant in both HT0(C ) and HTt(C ) (P<0.05). Fig. 6 . GFR in the hypertensive group randomly chosen for treatment with fosinopril during baseline and test clearance experiments, i.e. before and after protein ingestion, respectively. NT, normotensive controls (n=15); HT0(F ), hypertensive patients chosen for treatment with fosinopril during washout phase (n=8); HTt(F ), same hypertensive patients after long-term antihypertensive treatment with fosinopril (n=8). Error bars denote SEM. The difference in baseline GFRs between groups HT0(F ) and HTt(F ) is significant (P=0.0117). The difference between baseline and test GFRs is significant (P<0.0232) in HT0(F ), but not in HTt( F ).
was only a partial restoration of the normal haemoThe renal vascular resistance (RVR) for the normotensive controls, the patients with essential hypertendynamic response.
Since dynamic processes are generally more appro-sion, the patients treated with carvedilol, and the patients treated with fosinopril is shown in Figure 8 . priately characterized by fractional increases or decreases, and since GFR is determined more directly RVR was calculated by the formula of Gomez: RVR= ([MAP-10]/ERPF ) × 60 × 1322 × (1-Haematocrit) than ERPF, which is only approximated by the clearance of PAH, Figure 7 summarizes and accentuates (dyn/cm2)/(ml/s). Upon comparison of Figure 7 with Figure 8 , acute increases in GFR can be seen to the findings illustrated in Figures 3, 5 and 6 by means of the relative change in GFR, i.e. the difference correspond to decreases in RVR. Acute decreases in GFR, however, correspond to acutely unchanging between GFR before and after protein stimulation, divided by GFR before protein stimulation. RVRs. The asymmetrically complementary findings hint at the haemodynamic mechanism of the acute DGFR/GFR is referred to as renal functional reserve (RFR).
clearance changes to be discussed.
Fig. 7.
Relative change in GFR (DGFR/GFR=RFR), i.e. difference between test and baseline GFR before and after protein ingestion referred to baseline GFR. RFR, renal functional reserve; NT, normotensive controls (n=15); HT0, hypertensive patients during washout phase (n=16); HTt(C ), hypertensive patients (chosen from HT0) after long-term antihypertensive treatment with carvedilol (n=8); HTt( F ), hypertensive patients (chosen from HT0) after long-term antihypertensive treatment with fosinopril (n=8). Error bars denote SEM. The difference between NT and HT0 is highly significant (P<0.001). The difference between HT0 and HTt (C ) is also highly significant (P<0.001). The difference between HT0 and HTt (F ) is, however, not significant (P=0.1). Fig. 8 . RVR calculated by the formula of Gomez. NT, normotensive controls; HT0, hypertensive patients during washout phase; HTt(C ), hypertensive patients (chosen from HT0) after long-term antihypertensive treatment with carvedilol; HTt(F ), hypertensive patients (chosen from HT0) after long-term antihypertensive treatment with fosinopril. Difference between baseline and test RVR is significant in NT (P= 0.011). Difference in baseline RVRs between NT and HT0 is highly significant (P<0.001). Difference in baseline RVRs between NT and HTt(C ) is significant (P=0.0216). Difference in baseline RVRs between NT and HTt(F ) is not significant. mesangial contraction, since there were no concomitant Discussion decreases in ERPF ( Figure 4) . Instead, the dynamic renal responses to protein ingestion can be understood Using the system identification method of adapting a in terms of a preferentially pre-glomerular vascular two-compartment model to experimental concentradysfunction in patients with essential hypertension. tion profiles as illustrated in Figure 1 , we found This situation resembles that found in the so-called increases of GFR in normal controls, but 'paradoxical' captopril test where vasodilation of the efferent arteridecreases of GFR by~10% in patients with essential oles is achieved by the administration of captopril in hypertension by (Figure 3) . These acute decreases in kidneys with stenosed arteries, resulting in acutely GFR following protein ingestion cannot be explained decreased GFR and filtration fraction [18] . Similarly, by systemic blood pressure effects, since there were no consideration of the filtration process in renal vessel acute systemic changes in the MAP ( Figure 2) . Neither can these decreases in GFR be explained by acute resistances differentially altered between the vasa afferentia and the vasa efferentia should allow expecta-but rather to the antioxidative effect of carvedilol.
Other antioxidative agents must be tested to clarify tion of not only an absence of increases in GFR after protein ingestion, but even 'paradoxical' decreases in whether carvedilol plays a role in pharmacologicallymediated restoration of functional reactivity dimin-GFR concomitant with ERPFs that remain the same during dynamic tests. The interplay of the resistances ished by the effects of free radicals on endothelial cells [25] , and whether this repair is reflected in the almost of the vasa afferentia when remaining high and of the vasa efferentia when acutely reduced by a vasodilatory completely restored normal protein-induced acute relative change in GFR seen in our patients treated with stimulus leads to an acutely reduced GFR during preservation of the renal blood flow as observed in carvedilol.
There is a significant acute decrease in RVR upon previous studies in diabetics [19] . Since protein ingestion did not cause any acute reduction in systemic protein ingestion in the normotensive controls, whereas in the hypertensive patients during the washout period blood pressure ( Figure 2) , it probably interferes with glomerular filtration by reducing efferent vascular there is no acute change in RVR upon protein ingestion ( Figure 8) . However, while a tendency towards reconresistance in kidneys with no significant change in reactivity of the afferent vascular resistance to the stitution of reactivity to protein stimulation was found in patients treated with carvedilol, in patients treated dietary signal.
Impaired reactivity of afferent vascular resistance in with fosinopril a tendency towards long-term lowering of RVR was seen. This is in accordance with the patients suffering from long-term essential hypertension, as seen in Figures 4 and 8 , has been ascribed to finding that fosinopril has been shown to reduce structural, but not functional alterations in small arteries decreased bioavailability of nitric oxide (NO) due to increased levels of reactive oxygen species [20] . Since by interfering with growth factors in spontaneously hypertensive rats [26 ] . -arginine has been shown to have free-radical scavenging properties [21] and to serve as a substrate for
The RVR determinations both supplement and corroborate the conclusions drawn from the determina-NO synthesis, it may increase the bioavailability of NO [22] ; therefore, the dietary signal could be the tions of renal functional reserves. Thus the concept of decreased afferent reactivity and increased afferent -arginine contained in the applied protein-rich meal.
Increased RVR in our patients, as seen in Figure 8 , resistance in the hypertensive patients is supported by the increased and unchanging RVR seen during the is explained by the established modulation of the impact of NO on renal haemodynamics and glomerular washout period. Carvedilol appears to restore afferent reactivity, while fosinpril appears to reduce afferent function through oxidative stress on vascular endothelial cells [23] in essential hypertension. In our patients resistance.
The hypertensive patients studied had normal serum treated with the antihypertensive and antioxidative drug carvedilol, the change in GFR following the creatinine concentrations, normal creatinine clearance and no proteinuria. These patients revealed baseline protein load was negative before treatment, but positive after 6 months of therapy ( Figure 5 ). In contrast, GFRs in the normal range over the entire treatment period. Obviously, single GFR determinations cannot in the patients treated with the ACE-inhibitor fosinopril, the baseline and test GFRs did not differ signific-detect early alterations in renal function and renal haemodynamics. These become visible only by evaluatantly ( Figure 6 ).
In Figure 7 the negative value of DGFR/GFR in the ing the acute changes in GFR following a protein load. In contrast to previous studies finding only 'blunted untreated hypertensive patients in contrast to the positive value of DGFR/GFR in the normotensive controls increases', our study method was sensitive enough to detect acute decreases in GFR. However, the unchangindicates a pathological alteration in renal vascular reactivity. Again, a nearly complete normalization of ing RVR is complementary to the negative RFR in hypertensive patients as demonstrated in Figures 7 and the haemodynamic mechanism is shown in the carvedilol-treated group, but only a partial one in the fosinop-8. Our finding is in exact correspondence with a relevant previous finding of decreasing RVR in normoril-treated group. The high RFR in our carvediloltreated patients, and the increased resistance to low tensive subjects and of unchanging RVR in patients with essential hypertension [20] . Obviously, in deterdensity lipoprotein (LDL) oxidation found previously in an identical group of patients with essential hyper-mining PAH clearances, which are up to five times greater than inulin or sinistrin clearances, traditional tension [24] also treated with carvedilol show parallel long-term developments. The low RFR in our fosinop-constant infusion methods will attain qualitatively the same results as modern methods of system identificaril-treated group is paralleled by the resistance to LDL oxidation remaining low in a previously studied ACE tion within the short time horizons needed for dynamic experiments. inhibitor-treated group of patients with essential hypertension [24] .
After a period of scepticism about the usefulness of dynamic renal function tests [27] , our study demonSince both groups of hypertensive patients showed similar long-term decreases in MAP, and the MAPs of strates that modern compartmental analysis of kinetic clearance experiments enables detection of early stages the two groups did not differ from each other significantly either before or after the treatments, the above of intrarenal haemodynamic alterations in the development of hypertension when there are pronounced effect of carvedilol on renal haemodynamics does not seem to be primarily due to reduction of blood pressure disparities between pre-and post-glomerular vascular
